IBM Reinvents the Patient Portal

IBMIBM (NYSE: IBM) announced the next evolution of the patient portal, significantly expanding the types of information, alerts, recommendations and interactive coaching healthcare providers can offer to interact with their patients online.

The IBM Patient Empowerment System goes beyond simply allowing patients to schedule appointments online or access a personal health record. Based on new technology out of IBM Research, this next-generation portal helps patients be more involved in managing their own medical profiles. Healthcare organizations such as hospitals or clinics can host the system, allowing physicians and patients to sign in and benefit from advanced services that prevent harmful drug interactions, send alerts for medical problems, examine genetic profiles to prevent over or under dosage of mediation, and more.

The IBM Patient Empowerment System is a standards-based platform, enabling patients to integrate and manage their healthcare data for all medical needs, receive personalized recommendations or alerts for safer medical treatment, and immediately access data from a vast range of sources including: third-party health portals, hospital electronic medical record systems, sensors, home devices for monitoring health conditions, U.S. Food and Drug Administration (FDA) alerts, medical sites like PubMed, and more. IBM is previewing the system this week at CeBIT in Hanover Germany.

The technology has been developed in collaboration with physicians and administrators of the Gacheon University Gil hospital in Korea. Among the largest medical centers in Korea with approximately one million patients, the hospital recently decided to provide physicians and patients with access to the portal as part of a pilot project to increase efficiency and reduce costs.

"Today, patients want to be more involved in managing their clinical data, and are eager to discover relevant and useful medical information for their benefit," noted Dr. DongKyun Park from Gacheon University Gil Hospital in Korea. "By giving patients access to information that is relevant to them in an easy and understandable form, we can greatly improve patient safety during medical treatments."

The system's easy-to-use analytical services can reduce costs, increase safety and improve patient satisfaction. By integrating social and medical data from multiple sources, the system allows patients to take an active role in their treatment, bringing the interaction between patients and caregivers to a new level of collaborative teamwork.

The system is also designed to protect privacy at various levels of granularity, enabling members to exercise fine-grained control over the level of information in their profile that can be viewed by others and its usage.

"Most patients do not have the same access to information available to physicians, such as treatment updates or new warnings from the FDA," said Joseph Jasinski, IBM Research. "And physicians are not always privy to ongoing patient updates, such as eating habits or long-term monitoring of vital signs. These partial pictures limit the level of care that physicians can provide, as well as the care patients can provide for themselves. The IBM Patient Empowerment System merges these realms, bringing important data to both parties."

Although more public sources for medical information are becoming available on the Internet all the time, this onslaught often leaves patients more confused rather than more knowledgeable. Weeding out relevant and accurate information in this sea of data is difficult for the typical patient but the IBM Patient Empowerment System uses expert analytics to take into account a patient's personal medical history and offer decision support information that is appropriate for them.

One example where public knowledge could improve patient safety involves personalized alerts for adverse drug events (ADE) - incidents where different medications could be dangerous when taken together. The Kaiser Family Foundation estimates that 7,000 people per year die from medication errors alone - about 16 percent more deaths than those attributable to work-related injuries.

ADE contributes greatly to added expenses in hospitalization and insurance costs every year. This service uses the platform's knowledge-bases alongside public repositories for drug-drug, drug-disease, drug-food, and pharmacogenetics interactions; these are then analyzed together with the most current patient clinical and genetic data. The output is an alert that can be given at the point of care to avoid potential harm associated with various drug interactions.

For example, if a patient is already being treated with prescription medicines and wants to take an over-the-counter medication, she would log into the IBM Patient Empowerment System and add the name of the drug to her list of medications. The system immediately crawls through her medical data, performs deep analytics, and then issues a warning message with details about a potentially dangerous interaction between one of the drugs she's already taking and the new one.

Because the system incorporates the patient's genetic profile, it can also issue warnings to the patient and prescribing physician if certain dosages or drug combinations are problematic given her personal genetic variations. Such genetic variations can lead a person to metabolize certain drugs differently than the greater population, raising the risk of dangerous adverse drug reactions. This information might otherwise be unavailable or even unknown to her physician.

Other smart services developed as part of this healthcare portal include socio-medical search and personalized recommendation services. The system maintains a unique dataspace that represents social entities, such as patients and healthcare personnel, and their relationship with medical entities, such as medications, allergies, and treatment plans. The IBM Patient Empowerment System also offers search capabilities and recommendations about patients who suffer from similar problems, potential treatment plans, expert physicians, and more. These features are built on IBM's Big Data Analytics platform, which can process structured and unstructured data at scale and speed not possible with traditional data warehouse technologies, allowing the system to discover relations hidden in the data and correlate with external information.

Because the system is designed as a standards-based clinical data warehouse and supports standard interoperability profiles, it can also immediately incorporate any medical information from sensors, home medical devices, monitoring systems, labs, or hospital information systems. Moreover, this interoperability makes it possible to add new data sources or services at any time.

This solution is just one example of how IBM researchers are helping transform the healthcare industry by creating technologies that will simplify the complex interactions in the healthcare delivery process while optimizing outcomes, ultimately helping to make patient care smarter and lower costs. Another focal area is health analytics, which uses advanced analytic capabilities such as those of IBM's Watson computing system, to produce valuable and timely insight from the vast amount of medical data available. Watson's ability to analyze the meaning and context of human language, and quickly process information to find precise answers can assist decision makers, such as physicians, to unlock important knowledge and facts buried within huge volumes of information, and offer answers they may not have considered to help validate their own ideas or hypotheses. This paves the way for a more evidence-based healthcare system that offers more informed diagnosis and treatment plans for patients at lower costs for providers, insurers and patients.

The IBM Patient Empowerment System was born as a result of the collaboration among three IBM centers around the world: the IBM Ubiquitous Computing Laboratory in Korea; IBM Research - Haifa and IBM Research - China.

Related news articles:

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...